CFDA Provides Sponsors Guidance on Clinical Trials

The China Food and Drug Administration issued guidance on clinical trials to provide sponsors technical recommendations for developing drugs.

The document is intended to strengthen the quality of clinical trials and provide sponsors with advice on how to formulate a development strategy and design individual trials. It defines terms such as exploratory and pivotal clinical trials, and provides details on primary endpoints.